A. Rodrı́guez-Antolı́n

4.8k total citations · 2 hit papers
142 papers, 3.2k citations indexed

About

A. Rodrı́guez-Antolı́n is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, A. Rodrı́guez-Antolı́n has authored 142 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 53 papers in Surgery and 27 papers in Oncology. Recurrent topics in A. Rodrı́guez-Antolı́n's work include Prostate Cancer Treatment and Research (52 papers), Prostate Cancer Diagnosis and Treatment (43 papers) and Bladder and Urothelial Cancer Treatments (26 papers). A. Rodrı́guez-Antolı́n is often cited by papers focused on Prostate Cancer Treatment and Research (52 papers), Prostate Cancer Diagnosis and Treatment (43 papers) and Bladder and Urothelial Cancer Treatments (26 papers). A. Rodrı́guez-Antolı́n collaborates with scholars based in Spain, United States and Italy. A. Rodrı́guez-Antolı́n's co-authors include Andrew Protheroe, Nobuaki Matsubara, Kim N., Karim Fizazi, Luis Fein, B. Yа. Alekseev, Mustafa Özgüroğlu, Susan Feyerabend, Dingwei Ye and Peter De Porre and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

A. Rodrı́guez-Antolı́n

122 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

2017 1.4k citations Karim Fizazi, A. Rodrı́guez-Antolı́n et al. profile →
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

2019 517 citations Karim Fizazi, A. Rodrı́guez-Antolı́n et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Rodrı́guez-Antolı́n Spain	18	2.5k	782	665	634	564	142	3.2k
Robert Given United States	19	1.7k 0.7×	555 0.7×	474 0.7×	432 0.7×	268 0.5×	57	2.2k
Alberto Bossi France	28	1.8k 0.7×	561 0.7×	338 0.5×	487 0.8×	196 0.3×	106	2.6k
Ubirajara Ferreira Brazil	22	1.8k 0.7×	370 0.5×	447 0.7×	345 0.5×	362 0.6×	132	2.6k
Alicia K. Morgans United States	29	1.9k 0.7×	422 0.5×	429 0.6×	1.1k 1.7×	261 0.5×	202	3.4k
D.A. Loblaw Canada	29	2.5k 1.0×	487 0.6×	306 0.5×	587 0.9×	212 0.4×	88	3.4k
Amit Bahl United Kingdom	24	954 0.4×	300 0.4×	578 0.9×	932 1.5×	155 0.3×	181	2.4k
Sabine Brookman‐May Germany	19	1.1k 0.5×	357 0.5×	361 0.5×	327 0.5×	190 0.3×	125	1.7k
A. Akdaş Türkiye	19	1.8k 0.7×	255 0.3×	281 0.4×	507 0.8×	339 0.6×	102	2.7k
F. Zattoni Italy	11	4.6k 1.8×	601 0.8×	451 0.7×	852 1.3×	307 0.5×	22	5.2k
Hiroji Uemura Japan	27	1.2k 0.5×	276 0.4×	383 0.6×	696 1.1×	144 0.3×	232	2.7k

Countries citing papers authored by A. Rodrı́guez-Antolı́n

Since Specialization

Citations

This map shows the geographic impact of A. Rodrı́guez-Antolı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rodrı́guez-Antolı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rodrı́guez-Antolı́n more than expected).

Fields of papers citing papers by A. Rodrı́guez-Antolı́n

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rodrı́guez-Antolı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rodrı́guez-Antolı́n. The network helps show where A. Rodrı́guez-Antolı́n may publish in the future.

Co-authorship network of co-authors of A. Rodrı́guez-Antolı́n

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rodrı́guez-Antolı́n. A scholar is included among the top collaborators of A. Rodrı́guez-Antolı́n based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rodrı́guez-Antolı́n. A. Rodrı́guez-Antolı́n is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Medina‐Polo, José, et al.. (2025). Assessing the influence of recurrent urinary tract infections on sexual function: a case–control study. The Journal of Sexual Medicine. 22(3). 454–463.

Otero, Javier, et al.. (2024). Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort. Actas Urológicas Españolas (English Edition). 48(5). 371–376. 1 indexed citations

Guerrero‐Ramos, Félix, et al.. (2024). Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs. Cancers. 16(19). 3330–3330. 1 indexed citations

Arroba, Cristina Martín‐Arriscado, et al.. (2024). Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery. Urologic Oncology Seminars and Original Investigations. 42(8). 246.e15–246.e21.

Backhaus, M., et al.. (2023). European Association of Urology biochemical recurrence risk groups after radical prostatectomy: External validation and identification of independent risk factors for progression and death. Actas Urológicas Españolas (English Edition). 47(7). 422–429. 5 indexed citations

Medina‐Polo, José, et al.. (2023). Evaluation of Quality of Life and Self-reported Complications in Patients With Clean Intermittent Catheterization. Journal of Wound Ostomy and Continence Nursing. 50(5). 400–405. 2 indexed citations

Carles, Joan, R.A. Medina López, Javier Puente, et al.. (2023). Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis. Future Oncology. 19(12). 819–828. 1 indexed citations

Guerrero‐Ramos, Félix, et al.. (2023). Extrauterine Retroperitoneal Leiomyomas: 3 Case Reports and Review of the Literature. Urologia Internationalis. 107(8). 814–818.

Rubio, Carolina, et al.. (2023). Immune Predictors of Response after Bacillus Calmette–Guérin Treatment in Non-Muscle-Invasive Bladder Cancer. Cancers. 15(23). 5554–5554. 3 indexed citations

10.

Medina‐Polo, José, et al.. (2022). Ureteral Stenosis and Fistula after Kidney Transplantation. Urologia Internationalis. 107(2). 157–164. 5 indexed citations

11.

García‐Gómez, Borja, et al.. (2021). Seizures and Neuropsychiatric Toxicity in Patients with Non-Metastatic CRPC Treated with New Antiandrogens: Systematic Review and Meta-Analysis. Oncology Research and Treatment. 44(4). 154–163. 2 indexed citations

12.

Medina‐Polo, José, et al.. (2021). Iterative renal transplantation: our experience on third transplants. International Urology and Nephrology. 53(6). 1097–1104.

13.

Alcaraz, Antonio, A. Rodrı́guez-Antolı́n, Joaquı́n Carballido, et al.. (2021). Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients. Scientific Reports. 11(1). 19401–19401. 10 indexed citations

14.

García‐Rojo, Esther, Celeste Manfredi, Á. Tejido Sánchez, et al.. (2020). Impacto del brote de COVID-19 en las listas de espera de cirugía urológica y estrategias de priorización en la era post-COVID-19. Actas Urológicas Españolas. 45(3). 207–214. 16 indexed citations

15.

Otero, Javier, et al.. (2019). Analysis of Holmium Laser Enucleation of the Prostate in a High-Volume Center: The Impact of Concomitant Holmium Laser Cystolitholapaxy. Journal of Endourology. 33(7). 564–569. 8 indexed citations

16.

Rodrı́guez-Antolı́n, A., et al.. (2019). PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study. BMC Urology. 19(1). 92–92. 27 indexed citations

17.

Otero, Javier, Borja García‐Gómez, José Medina‐Polo, et al.. (2018). The Brief Sexual Symptom Checklist as a Screening Tool for Sex-Related Problems in the Primary Care Setting: Focus on Erectile Dysfunction. Urologia Internationalis. 101(1). 98–105. 5 indexed citations

18.

Martínez‐Piñeiro, Luis, et al.. (2016). Prevalence and severity of fatigue in castration resistant prostate cancer in Spain: VITAL study. Annals of Oncology. 27. vi251–vi251. 1 indexed citations

19.

Otero, Javier, et al.. (2014). Evaluation of Current Errors Within the Administration of Phosphodiesterase-5 Inhibitors After More Than 10 Years of Use. Urology. 83(6). 1334–1338. 14 indexed citations

20.

Otero, Javier, et al.. (2006). La anestesia local mejora significativamente la tolerancia de la biopsia prostática. Archivos Españoles de Urología. 59(4). 407–14. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact